Brain health supplements market seen reaching $26.38B by 2035

The global brain health supplements market is projected to grow from $10.48 billion in 2026 to $26.38 billion by 2035, driven by rising neurodegenerative disease rates, aging populations and e-commerce expansion. Market Research Future says the category is moving from niche wellness to a mainstream preventive-health market.

Why it matters: - The brain health supplements market is shifting from a discretionary wellness category to a preventive health market tied to aging, cognition and chronic disease awareness. - The projected growth reflects demand from older consumers, caregivers and digital-first buyers. - Governments and health agencies are also backing research that could strengthen product credibility and consumer adoption.

What happened: - Market Research Future projects the global brain health supplements market will rise from $10.48 billion in 2026 to $26.38 billion by 2035. - The forecast implies a 10.80% compound annual growth rate from 2026 to 2035. - The market was estimated at $9.46 billion in 2025. - The release ties the outlook to rising neurodegenerative disease prevalence, aging demographics and e-commerce growth. - A free sample is available here.

The details: - Alzheimer’s Association data cited in the release shows about 6.9 million Americans age 65 and older were living with Alzheimer’s disease in 2024. - The World Health Organization projects 139 million global cases by 2050. - The release says people over 50 spend two to three times more on cognitive health products than younger consumers. - Online supplement sales in the United States grew 14.8% year over year in 2024. - Brain health ranked among the top five search terms on Amazon and iHerb. - Subscription models account for an estimated 22% of direct-to-consumer supplement revenue. - National health agencies across the EU committed more than EUR 1.2 billion to dementia-prevention research programs through 2030. - The U.S. National Institutes of Health allocated $3.7 billion to neuroscience research in fiscal 2024. - National dementia plans in the United States, Japan and the United Kingdom now reference nutritional supplementation as a complementary intervention. - The release also points to public funding for observational studies of omega-3 fatty acids and B-vitamin complexes. - The report identifies vitamins and minerals as the dominant product type, with about 42% revenue share in 2025. - Natural molecules are the fastest-growing product class, with a 12.6% CAGR from 2026 to 2035. - Herbal extracts generated $2.46 billion in 2025. - Memory enhancement was the largest application segment, with about 28% of global demand in 2025, or roughly $2.65 billion. - Stress and anxiety is the fastest-growing application segment at 13.1% CAGR. - Sleep and recovery reached $1.32 billion in 2025. - Attention and focus reached $1.58 billion in 2025. - Anti-aging and longevity is growing at 12.9% CAGR. - Depression and mood is growing at 11.4% CAGR. - E-commerce and direct-to-consumer channels are the fastest-growing distribution route. - Retail pharmacies and health food stores held about 38% share in 2025. - North America held about 39% share in 2025 and remains the dominant regional market. - Europe was the second-largest region with about 26% share in 2025. - Asia-Pacific is the fastest-growing region, at 13.2% CAGR from 2026 to 2035. - The Middle East and Africa region is growing at 8.9% CAGR from 2026 to 2035. - The market is highly fragmented, with an estimated Herfindahl-Hirschman Index below 500. - The top five players account for roughly 22% to 28% of global revenue. - Recent company milestones cited include Neuriva Ultra from Reckitt Benckiser in March 2025, Prevagen from Quincy Bioscience in 2024-2025, Nature’s Bounty and Garden of Life brain formulas from Nestlé Health Science in 2024-2025, and NOW Brain Elevate and True Focus from NOW Foods in 2024-2025.

Between the lines: - The forecast depends on more than consumer wellness trends. It is also being shaped by research spending, pharmacy recommendations and digital commerce infrastructure. - The report suggests brands with clinical positioning and branded ingredients may gain share faster than generic supplement players. - AI-driven formulation, consumer genomics and cognitive training apps could change how these products are developed and sold over the next decade.

What's next: - The report expects AI-optimized formulation to accelerate ingredient discovery and product development by 2030. - It also forecasts that 15% to 20% of new brain supplement SKUs may come from AI-optimized formulation engines by 2030. - Supplement brands are likely to keep expanding into subscription, app-based and biomarker-driven offerings. - The report anticipates deeper convergence between supplements and digital cognitive training platforms through the early 2030s.

The bottom line: - The brain health supplements market is moving toward a larger, more evidence-driven and digitally distributed category, with growth anchored by aging populations and rising concern about cognitive decline.